Challenges and future of renal replacement therapy

@article{Francisco2006ChallengesAF,
  title={Challenges and future of renal replacement therapy},
  author={Angel Luis Mart{\'i}n Francisco and C. Pi{\~n}era},
  journal={Hemodialysis International},
  year={2006},
  volume={10}
}
Renal community increasingly recognizes the challenges of very high mortality, morbidity and low quality of life among dialysis patients. Current hemodialysis (HD) schedule provides less than 10% of the clearance power of the natural kidneys and therefore current standard HD treatment is still a long way from providing adequate renal replacement. In the future it would be expected to improve dialysis control with the development of new technology: membranes, dialysate buffer, electrolyte… Expand
Technological advances in renal replacement therapy: five years and beyond.
The worldwide epidemic of chronic kidney disease shows no signs of abating in the near future. Current dialysis forms of renal replacement therapy (RRT), even though successful in sustaining life andExpand
Calculation of the clearance requirements for the development of a hemodialysis‐based wearable artificial kidney
TLDR
The present study provided theoretical dialysis doses for an HD‐based WAK system to achieve various target TACs through relevant mathematical kinetic modeling and may contribute to the determination of the technical specifications required for the development of a W AK system. Expand
Pediatric renal supportive therapies: the changing face of pediatric renal replacement approaches
TLDR
The terms ‘chronic kidney disease’ and ‘acute kidney injury’ have replaced the terms chronic renal failure and acute renal failure, respectively, and the terminology of ‘renal replacement therapy’ should be supplanted by more appropriate terminology, “renal supportive therapy”. Expand
Did 20 years of technological innovations in hemodialysis contribute to better patient outcomes?
TLDR
Overall, the major technological advances in dialysis have not yet been translated into longer patient survival, and observational data suggest an advantage of convective over pure diffusive strategies in the long-term outcome of the dialysis patient. Expand
Computational dose predictions for combined treatment of hemofiltration with weekly hemodialysis
TLDR
The results by a computer simulation show that CT can reduce the frequency of sessions and the volume of replacement fluid compared with daily convective treatment, and achieve the adequate treatment efficiency with both small and intermediate-sized molecules for chronic renal failure patients. Expand
AYURVEDIC MANAGEMENT OF CHRONIC KIDNEY DISEASE: A CASE STUDY
In recent years, chronic kidney disease (CKD) has received increasing attention owing to its enhancing rate of prevalence. Patients with CKD are at increased risk for cardiovascular morbidity andExpand
Renal replacement therapy and its impact on the cardiac patient
TLDR
There will be a discussion throughout this article of the continual inter face of CVD and RRT and the management of patients at stage 5 CKD. Expand
Dialysis adequacy in patients of Abadan hemodialysis
  • 2019
Aims: According to ambiguous status of quality of dialysis in Abadan, this study was performed to evaluate the dialysis adequacy in Abadan hemodialysis center in 2007. Methods: In thisExpand
Enabling Innovative Translational Research in Acute Kidney Injury
TLDR
This review will summarize the advances, ongoing studies, and future perspectives in the field of translational research of AKI, which involves the transition between the basic research discoveries and everyday clinical applications to prevent, diagnose, and treat human diseases. Expand
Advances in Hemodialysis Techniques
TLDR
Hemodialysis treatment is provided for critically ill patients with acute kidney injury as in‐ patient therapy and at home, where it can be self-initiated and managed or done jointly with the assistance of a trained helper who is usually a family member. Expand
...
1
2
3
...

References

SHOWING 1-10 OF 32 REFERENCES
Future developments in the treatment of end-stage renal disease: a North American perspective.
  • L. Henderson
  • Medicine
  • American journal of kidney diseases : the official journal of the National Kidney Foundation
  • 2000
TLDR
Near-term changes in current vascular access technology will be driven by the current cost of access failure, and online compounding of solution for use is likely for both hemodialysis and peritoneal dialysis. Expand
Initial clinical results of the bioartificial kidney containing human cells in ICU patients with acute renal failure.
TLDR
The addition of human renal tubule cell therapy to CRRT has been accomplished and demonstrates metabolic activity with systemic effects in patients with ARF and MOF, and initial clinical results are encouraging. Expand
Dialysis dose and frequency.
TLDR
There is no reason to reduce arbitrarily dialysis dose, particularly dialysis treatment time in HD patients treated three times weekly, and daily HD represents a very promising tool for improving dialysis outcomes and quality of life, although its impact on patient survival has not yet been proven definitively. Expand
Dose of dialysis: key lessons from major observational studies and clinical trials.
  • R. Saran, B. Canaud, +4 authors F. Port
  • Medicine
  • American journal of kidney diseases : the official journal of the National Kidney Foundation
  • 2004
TLDR
Data from observational studies, including the DOPPS, and from the HEMO Study are critically examined, emphasizing important lessons from both, and future paradigms for achieving dialysis adequacy to improve patient outcomes are discussed. Expand
On-line haemodiafiltration versus low-flux haemodialysis. A prospective randomized study.
  • V. Wizemann, C. Lotz, F. Techert, S. Uthoff
  • Medicine
  • Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
  • 2000
TLDR
In the absence of any side-effects of on-line HDF and supposing that plasma beta2-microglobulin is a marker of morbidity, on- online HDF ensures an excellent dialysis quality which apparently takes time to translate into measurable clinical sequelae. Expand
Effect of dialysis dose and membrane flux in maintenance hemodialysis.
TLDR
Patients undergoing hemodialysis thrice weekly appear to have no major benefit from a higher dialysis dose than that recommended by current U.S. guidelines or from the use of a high-flux membrane. Expand
Frequent prolonged home haemodialysis: three old concepts, one modern solution.
  • M. Kooistra
  • Medicine
  • Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
  • 2003
TLDR
Dialysis should be referred to as ‘adequate’ when it results in normal life expectancy, normal morbidity, normal quality of life and the absence of dialysis-associated symptoms. Expand
Convective treatments with on-line production of replacement fluid: a clinical experience lasting 6 years.
TLDR
It is concluded that OL-prepared replacement fluid is as safe as that of the commercial bags with regard to sterility and non-pyrogenicity and can be readily implemented in any dialysis centre without bringing any further burden on the staff. Expand
Comparison of mortality in ESRD patients on convective and diffusive extracorporeal treatments. The Registro Lombardo Dialisi E Trapianto.
TLDR
The hypothesis that convective treatments are associated with a nonsignificant trend toward better survival and significantly delay the need for CTS surgery is supported. Expand
Clinical and microbiological evaluation of a postdilutional hemofiltration system with in-line production of substitution fluid.
TLDR
GHS-10 used in this study for postdilutional HF confirms that a large quantity of intravenous quality fluid may be safely produced by ultrafiltration from Dialysate and introduced a new dimension in biocompatibility of dialysis by demonstrating that sterile dialysate may be routinely produced and used for routine dialysis. Expand
...
1
2
3
4
...